Company news
Bio-gene Technology Ltd. (ASX:BGT) news
Bio-gene Technology Ltd. news releases on 6ix. Latest, Aug 28, 2026: Appendix 4E and 2026 Annual Report
Press releases & updates
Appendix 4E and 2026 Annual Report
August 27, 2026
Results of Placement
May 25, 2026
Sumitomo & Nakashima to launch Qcide products in Japan
March 15, 2026
Regulatory Development of Flavocide
March 2, 2026
Appendix 4D and Half-Year Accounts 31 December 2025
February 23, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
U.S. Department of Defense Grant Programs Advance
December 17, 2025
Bio-Gene Receives $519,500 R&D Tax Incentive
November 24, 2025
CEO's Presentation
November 19, 2025
Chair's Address to Shareholders
November 19, 2025
Qcide receives organic listing status in USA
November 13, 2025
Response to ASX Aware Letter
September 29, 2025
Positive Flavocide Efficacy Results Presented
September 22, 2025
Appendix 4E and 2025 Annual Report
August 25, 2025
Result of Security Purchase Plan
June 2, 2025
Launch of Security Purchase Plan
May 12, 2025
Investor Presentation - Placement
May 5, 2025
Result of Placement
May 5, 2025
Trading Halt
April 30, 2025
Bio-Gene Presentation - NWR Virtual Healthcare Conference
March 19, 2025
Appendix 4D and Half-Year Accounts 31 December 2024
February 27, 2025
BGT Investor Webinar 4-Feb-25 Slides
February 3, 2025
BGT Awarded U.S. Department of Defense Grants
January 28, 2025
CEO's Address to Shareholders
November 29, 2024
Bio-Gene Receives $535000 R&D Tax Incentive
October 24, 2024
BGT Investor Presentation Oct24
October 1, 2024
Investor Webinar Presentation 06 Sep 24
September 5, 2024
Bio-Gene & Rallis achieve key Flavocide production milestone
September 1, 2024
Appendix 4E and 2024 Annual Report
August 27, 2024
Envu collaboration on Flavocide for mosquito management
August 13, 2024
APVMA Pre Application Assistance
August 7, 2024
Investor Webinar - FY24 Half Year Review
March 4, 2024
Appendix 4D - Half Year Accounts - 31 December 2023
February 25, 2024
Appendix 4C - 31 December 2023
January 28, 2024
Bio-Gene Receives R&D Tax Incentive
January 18, 2024
Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan
December 12, 2023
BGT Corporate Presentation
December 12, 2023
BGT 2023AGM - CEO's Presentation
November 23, 2023
BGT 2023AGM - CEO's Address
November 23, 2023
BGT 2023AGM - Chairman's Address
November 23, 2023
Result of Share Purchase Plan Offer (SPP)
October 3, 2023
Launch of SPP & Further Funds Raised under Placement
September 11, 2023
Capital Raise & Presentation
September 1, 2023
BGT Update Company Presentation
August 11, 2023
New USA Patent for the Insecticide Market
August 1, 2023
Appendix 4E and 2023 Annual Report
July 31, 2023
BGT Appoints New CEO
July 28, 2023
BGT Executes Agreement with STK
July 26, 2023
BGT selected for USA CDC Funded Program
July 23, 2023
Allowance of USA Patent
June 28, 2023